Paroxetine Tablet, Film Coated
Product Images NDC 70518-3430

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-3430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 01)
Chemical structure of paroxetine hydrochloride, showing its molecular arrangement with oxygen, fluorine, nitrogen atoms, and a HCl group as part of the molecule.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 02)
A chart showing the fold change and 90% confidence interval for the pharmacokinetic parameters Cmax and AUC of various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The horizontal axis is on a logarithmic scale indicating change relative to reference.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 03)
A forest plot showing fold change and 90% confidence intervals in pharmacokinetic parameters Cmax and AUC for Paroxetine when coadministered with several interacting drugs (Cimetidine 300 mg TID, Phenobarbital 100 mg QD, Phenytoin 300 mg QD, Digoxin 0.25 mg QD, Diazepam 5 mg TID). The x-axis indicates change relative to reference from 0 to 2.*
FDA Label Image

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)

Image (3dbda37c 9453 474f A247 Fceb50497ae8 04)
A forest plot chart showing pharmacokinetic changes (Cmax, AUC, Cmin) with 90% confidence intervals for Paroxetine across different population groups, including renal impairment (mild, moderate, severe), hepatic impairment, age over 65 at various doses, and males. The x-axis represents fold change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Mm1 (Paroxetine 10mg 70518 3430 00)

Mm1 (Paroxetine 10mg 70518 3430 00)
Paroxetine 10 mg tablet packaging label showing quantity of 90 tablets. The label indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. It includes storage instructions, manufacturer details (Zydus Pharm, Pennington, NJ), and dosing advice to see insert. The label also has the NDC 70518-3430-00 and is marked RX ONLY.*
FDA Label Image

Mm2 (Paroxetine 10mg 70518 3430 01)

Mm2 (Paroxetine 10mg 70518 3430 01)
Label for Paroxetine 10 mg film-coated tablet by RemedyRepack Inc. The label shows tablet quantity of 30 and includes standard prescription information such as the NDC number 70518-3430-01, manufacturer details (Zydus Pharm, Pennington, NJ), storage instructions, and a barcode. The packaging specifies the product is Rx only and advises to keep out of reach of children.*
FDA Label Image

Mm3 (Paroxetine 10mg 70518 3430 02)

Mm3 (Paroxetine 10mg 70518 3430 02)
Paroxetine 10 mg film-coated tablets packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-3430-02, mentions it is repackaged by Remedy Repack Inc., and provides storage instructions and usual dosage note. The manufacturer is Zydus Pharm, Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.